UltraTech Cement Limited appears to be a financially healthy company, with strengths in its high gross margins (57.71%) and EBITDA margins (16.53%). However, its profitability metrics, such as ROE (9.00%) and profit margins (7.95%), are relatively low. The company's valuation is high, with a trailing P/E of 56.49 and forward P/E of 84.49, indicating that it may be overvalued. The debt-to-equity ratio of 32.62% is manageable, but the company's growth metrics, including revenue growth (13%) and earnings growth (7.7%), are modest. Overall, the company's financial health is stable, but its high valuation and modest growth rates may be concerns for investors.